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Inhibition of p73 Function
by Pifithrin-α as Revealed by
Studies in Zebrafish Embryos
William Davidson,1,2,* Qing Ren,1 Gabor Kari,1 Ori Kashi,1 Adam P. Dicker1 and
Ulrich Rodeck3
1
Departments of Radiation Oncology, 2Biochemistry & Molecular Biology; and 3Dermatology
and Cutaneous Biology; Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.

The following article is reprinted with permission from Landes Bioscience. It was originally
published in Cell Cycle, Volume 7, Issue 9, pp. 1224-1230.

Abreviations: MO, antisense morpholino oligonucleotide; PFTα, pifithrin-α;
Hpf, hours post fertilization; Kd, knock down; IR, ionizing radiation
Key Words: zebrafish, development, radiation effects, tumor suppressor
protein p53, tumor suppressor protein p73, pifithrin-α
The p53 family of proteins contains two members that have been implicated in sensitization of cells
and organisms to genotoxic stress, i.e., p53 itself and p73. In vitro, lack of either p53 or p73 can protect certain cell types in the adult organism against death upon exposure to DNA damaging agents.
The present study was designed to assess the relative contribution of p53 to radiation resistance of
an emerging vertebrate model organism, i.e., zebrafish embryos. Consistent with previous reports,
suppressing p53 protein expression using antisense morpholino oligonucleotides (MOs) increased
survival and reduced gross morphological alterations in zebrafish embryos exposed to ionizing
radiation. By contrast, a pharmacological inhibitor of p53 function [Pifithrin-α (PFTα)] caused
developmental abnormalities affecting the head, brain, eyes and kidney function and did not protect against lethal effects of ionizing radiation when administered at 3 hours post fertilization (hpf).
The phenotypic abnormalities associated with PFTα treatment were similar to those caused by
antisense MO knock down (kd) used to reduce p73 expression. PFTα also inhibited p73-dependent
transcription of a reporter gene construct containing canonical p53-responsive promoter sequences.
Notably, when administered at later stages of development (23 hpf), PFTα did not cause overt developmental defects but exerted radioprotective effects in zebrafish embryos. In summary, this study
highlights off-target effects of the pharmacological p53 inhibitor PFTα related to inhibition of p73
function and essential roles of p73 at early but not later stages of zebrafish development.

Introduction
The genotoxic stress response is one of the most widely studied phenomena in biology and the
efforts of many groups have provided a detailed understanding of the molecular determinants of
this homeostatic mechanism (reviewed in refs. 1–3). Yet, the current understanding of the effects of
genotoxic stress on whole organisms is curtailed by the fact that many of the mechanistic insights are
based on experiments with cultured cells. These shortcomings are compounded by pitfalls associated
with the preferential use of immortalized or transformed cells.4 In recognition of these problems,
many groups have resorted to studying the DNA damage response in experimental animals, particularly genetically engineered mice. These efforts have contributed considerably to the understanding
of molecular determinants of the in vivo genotoxic stress response including Ku,5,6 DNA-PK,7 DNA
ligase IV,8 ATM,9 ATR,10 Chk111 and Chk2.12 In addition, these studies confirmed a central role of the
tumor suppressor p53 in the genotoxic stress response (reviewed in refs. 13 and 14).
The present study was undertaken to explore molecular determinants of the genotoxic stress
response in an emerging animal model system, i.e., zebrafish embryos. Zebrafish represents a
vertebrate species with many similarities to mammals. Yet, they breed prolifically and are amenable to large-scale phenotypic screening facilitated by the fact that they are transparent during
organogenesis. Importantly, ‘knockdown’ strategies using antisense MOs have been developed in

this species to investigate protein function in
the in vivo context. Zebrafish are attractive
not only to model human diseases but also as
tools in drug discovery.15 We have previously
reported that zebrafish embryos provide a
rapid, facile system to identify pharmacological modifiers of the radiation response.16 Here,
we extend these studies to assess the contribution of endogenous modifiers of the radiation
response to radiation-induced morbidity and
mortality by focusing on pharmacological and
genetic inhibition of p53 function.

Results and Discussion
Time- and dose-dependent effects of ionizing radiation on zebrafish embryo survival.
Previously, we observed that radiation sensitivity of zebrafish embryos was different at
distinct developmental stages and progressively decreased between 2 to 8 hours post
fertilization (hpf ).16 Here, we extend this earlier
study by assessing embryo survival after exposure to increasing radiation doses up to 72 h
after radiation. These experiments confirmed
progressive radioresistance at successive stages
of development (not shown). To determine
the consequences of inhibiting translation of
specific gene products by antisense MO kd for
radiation resistance of the developing embryo
we performed all subsequent experiments in
embryos which were irradiated at 24 hpf. This
was based on the consideration that, at this time
point, target protein expression is sufficiently
suppressed by antisense MO kd and remains
low for extended time periods up to 4 days post
fertilization (dpf ).17 Dose-dependent survival
upon radiation exposure at 24 hpf revealed
100% lethality scored at 6–7 dpf (40 Gy) with
an LD50 of 20 Gy.18 To monitor the effects of
p53 expression on radiation sensitivity as it
relates to both, mortality and tissue-specific
effects, we thus performed experiments at 20
or 40 Gy.
Reduced p53 expression is associated
with radioprotection of zebrafish embryos.
Zebrafish embryos harboring homozygous
missense p53 mutations exhibit increased
resistance to the deleterious effects of ionizing
radiation.19 We determined whether suppressing
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Effects of the pharmacological p53 inhibitor PFTα on development
and radiation sensitivity of zebrafish embryos. PFTα was originally
identified as an inhibitor of p53-dependent transcription22 and it reduced
the sensitivity of mice to the deleterious effects of ionizing radiation.23
Based on these previous studies we tested whether PFTα also protected
zebrafish embryos against radiation-associated toxicity (Fig. 2A). Unexpectedly, when added to zebrafish embryos at 3 hpf (sphere stage), PFTα
(2 μM) caused malformations affecting the head region and led to the
development of massive edema affecting the whole body of treated fish
at later stages of development (Fig. 2B and Table 1). Furthermore, it has
been described earlier that PFTα treatment also reduces overall survival
of zebrafish embryos.21 These results together raised the question whether
PFTα exerted effects on molecular targets other than p53, which confound
potential radioprotective properties of PFTα in the zebrafish embryo.
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Figure 1. Antisense morpholino oligonucleotides (MOs) targeted to
p53 increase embryo survival and reduce ionizing radiation-induced
apoptosis evident in the head and trunk regions. (A) Embryo survival.
Triplicate dishes of 60 embryos each were scored for live embryos daily
after 20 Gy IR administered at 24 hpf. Necrotic dissolution or absent
heartbeat were considered criteria for embryo death. (B) Restoration of
IR sensitivity by restoring p53 expression using G-capped zebrafish p53
mRNA. Triplicate dishes of 60 embryos each were scored as described
above at 6 dpf (5 days post IR). Asterix (*) p53kd vs p53kd-p53 mRNA; p
< 0.05; t-test, one-tailed). (C) Attenuation of IR-induced apoptosis by p53
kd as assessed by quantification of acridine orange (AO) staining at 30
hpf. Sixty embryos per condition (Control, phenol red control; p53 mm,
mismatch antisense MO; p53 kd, p53 antisense MO; p53 kd-p53mRNA,
rescue coinjection with p53 antisense MO and p53 G-capped mRNA)
were pooled and stained with AO as described in Materials and Methods.
Pooled embryos were transferred to 95% ethanol for 15 minutes to
extract the AO for fluorescence determination. Triplicate measurements
for each condition were performed on a FL600 microplate fluorescence
reader (Bio-Tek) and normalized to control background fluorescence
and reported as relative fluorescence units (RFU).
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p53 expression by antisense MOs20 similarly induced a radioresistant
phenotype. We observed that p53-targeted MO kd markedly improved
survival of zebrafish embryos irradiated with 20 Gy at 24 hpf (Fig. 1A)
whereas coinjection of capped p53 mRNA restored radiation sensitivity
(Fig. 1B). Similarly, p53-targeted MO kd markedly reduced the incidence
and severity of radiation-induced morphological defects, notably defects
in midline development that manifest as dorsal curvature of the body
axis (Fig. S1). These results were similar to results by Duffy and Wickstrom published during preparation of this manuscript.21 In addition,
p53-targeted MO kd markedly reduced the extent of radiation-induced
apoptosis as determined by acridine orange staining (Fig. 1C).

PFTα treatment mimics morphological effects associated with knockdown of p73 expression in zebrafish embryos. P73 is a likely candidate
for off-target effects of PFTα because p73 binds to and transactivates
p53 responsive promoters.24 Thus, we determined whether suppression
of p73 expression by antisense MO kd caused developmental defects
similar to those observed in PFTα treated embryos. A previous report
showed that targeting p73 adversely affected development of the head
region, i.e., the olfactory system, the telencephalon and the pharyngeal
arches of zebrafish embryos.25 In addition, p73 is expressed at high levels
in the developing kidneys.26 We observed that p73-targeted antisense
MO-mediated kd induced head region abnormalities (Fig. 3A) and led
to liquid accumulation affecting the whole body of treated fish (Fig. 4
and Table 2). These changes were very similar to the morphological
alterations observed in PFTα-treated fish (Fig. 2B). Furthermore, alcian
blue staining revealed severe disturbances of branchial arch development
associated with either PFTα treatment or p73-targeted antisense MO kd
(Fig. 3B). These defects were, at least partially, reversed by coinjection
of G-capped p73 mRNA and not observed in embryos injected with p73
mismatched antisense MO.
Impaired kidney function in zebrafish treated with PFTα and p73
morpholinos. This is the first report of edema formation upon treatment
of developing embryos with p73-targeted antisense MO kd. We hypothesized that this phenotype was due to impaired renal clearance consistent
with high-level expression of p73 in the developing kidneys.26 To address
this issue we used a renal function assay, which measures retention of a
fluorescent dextran within 24 h after injection into the cardiac venoussinus.27 As compared to control fish receiving mismatch antisense MO,
the p73-targeted antisense MO kd caused markedly reduced clearance
of this contrast agent (Fig. 5). In contrast, control p53-specific antisense
MO kd did not affect dextran retention. Importantly, PFTα treatment not
only led to liquid accumulation in fish embryos in a manner similar to
p73-targeted antisense MO kd but it also increased dextran retention in
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Figure 2. PFT-α (2 μM) administered to zebrafish embryos at 3 hpf does not protect against the lethal effects of IR and is associated with developmental
abnormalities. (A) Embryo survival scored as described in Figure 1A. (B) Embryo morphology in the different experimental conditions as indicated.
Representative embryos were digitally photographed at 4x magnification and processed using NIH ImageJ software.

Table 1.
Incidence of whole body edema caused by PFTα treatment
Normal

Edema

Total

Edema (%)

Control

77

0

77

0

PFTα (2μM)

18

29

47

62

Triplicate dishes (30 embryos each per condition) of live embryos at 7 dpf were scored for edema as shown
in Figure 2B and results expressed as percent edema.

a similar fashion. In these experiments, kidney function was tested at 3
dpf and prior to the development of edema to avoid confounding effects
of the liquid accumulation on embryonal kidney function.
An alternative explanation for the profound edema in zebrafish embryos
following IR exposure is that this effect was caused by reduced cardiac
function.28 To investigate this possibility, we performed time-lapse
microscopy of cardiac contractility in control and irradiated fish embryos.
Quantitative analysis of the images revealed only marginal effects of
either PFTα treatment or p73-specific antisense MO kd on heart rate
and blood flow (not shown). Collectively, these results suggest that the
edema observed in PFTα and p73 antisense MO kd zebrafish embryos is
due primarily to compromised renal function.
PFTα inhibits p73-dependent transactivation of a p53-responsive promoter construct. The striking similarities in developmental
abnormalities caused by either PFTα treatment of suppression of p73
expression raised the question whether PFTα targeted not only p53dependent but also p73-dependent transcription. Using a p53 responsive
reporter gene construct and zebrafish p53 and p73 expression plasmids
cotransfected into Saos-2 cells we observed that PFTα not only inhibited
p53-dependent transcription but also p73-dependent transcription in a
dose-dependent manner (Fig. 6).
It should be noted that administration of PFTα shortly before radiation
(i.e., at 23 hpf ) did not cause developmental abnormalities either of the
craniofacial region or systemic edema and provided a measure of protection against radiation similar to that observed in p53 antisense MO kd
fish (Fig. S1). This result indicates that p73 serves essential functions
during the first 24 h of zebrafish development but is less relevant at later

developmental stages and, presumably, in the adult organism. This circumstance also explains why inhibition of p73 function by PFTα has not
been obvious in previous in vitro or in vivo studies in adult mice.
In summary, this report demonstrates the utility of the zebrafish
model system in characterizing drug effects and highlights previously
unrecognized effects of the p53 inhibitor PFTα related to inhibition
of p73 function. Lack of either p53 or p73 function is associated with
chemoresistance of transformed cells.29 Furthermore, p73 is induced
after DNA damage by the checkpoint kinases Chk1 and Chk2.30 Based
on these results, p73 has been considered as the “assistant” guardian
of the genome that acts in concert with p53 to limit propagation of
cells with damaged DNA.31 Since we observed that PFTα inhibits not
only p53-dependent but also p73-dependent transcription the overall
radioprotective effect of PFTα as observed in mice may, thus, be due to
inhibition of p53 and p73 function. Indeed, short-term pharmacological
inhibition of both, p53 and p73 may be superior to inhibition of p53
alone to protect normal adult cells and tissues against deleterious effects
of radiation.

Materials and Methods
Embryo harvesting and maintenance. Zebrafish husbandry, embryo
collection, dechorionation and embryo maintenance were performed
according to accepted standard operating procedures32 and with approval
by the Institutional Animal Care and Use Committee at Thomas Jefferson University. Zebrafish were maintained in the Zebrafish Core Facility
of the Kimmel Cancer Center at Thomas Jefferson University at 28.5°C
on a 14-h light/10-h dark cycle.
Zebrafish morphology by visual analysis. For visual analysis, zebrafish
embryos were anesthetized with 0.003% tricaine, placed on 3% methylcellulose on a glass depression slide and analyzed using an Olympus
BX51 microscope (Olympus, Melville, NY) at 4x magnification. Images
were recorded using a SPOT camera and SPOT Advanced software
(SPOT Diagnostic Instruments, Sterling Heights, MI).
Targeted knock down of gene expression. Antisense MO sequences
targeting p53, p73 and controls (5 base mismatches; p53 mm, p73 mm)
were as described.20,25 For microinjection, a 0.5 mM oligonucleotide solution was prepared in 10x phosphate-buffered saline solution, diluted 9:1
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Figure 4. Phenotypic abnormalities associated with PFT-α treatment
are similar to those caused by MO-mediated p73 kd. PFT-α was administered at 3 hpf. Embryo morphology and rescue by G-capped mRNA.
Representative embryos were digitally photographed at 4x magnification
and processed using NIH ImageJ software.
Table 2. Incidence of whole body edema caused by p73kd
Normal

B
Control

PFT-α 2 μM

Edema

Total

Edema (%)

Control

219

1

220

0

p73 MO

121

126

247

51

p73 mm
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4

68

6

p73 MO/mRNA

151

37
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20

Live embryos at 7 dpf were scored for edema as described in Figure 4 and results expressed as
percent edema.
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Figure 3. PFT-α treatment (2 μM at 3 hpf) affects cranio-facial development reducing brain, eye and auditory organ size. (A) Embryo head
morphology at 6 dpf. Representative embryos were digitally photographed at 10x magnification and processed using NIH ImageJ software
(a) snout, (b) eyes, (c) auditory cup. (B) Alcian blue staining (described
in Materials and Methods) of cartilage shows markedly abnormal
cranio-facial development associated with PFT-α treatment and with
p73 antisense MO kd.
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(v:v) with Phenol Red dye, and ~1 nL injected into 1–4 cell embryos
using a nitrogen gas pressure injector (Harvard Apparatus, Cambridge,
MA). To account for non-specific effects of MO oligonucleotides, rescue
experiments were carried out by coinjection of MOs with G-capped
mRNA of the respective target gene. To this end, triplicate dishes of 60
embryos were injected with 4.5–7.5 pg of mRNA generated by cloning the zebrafish p53 cDNA or p73 cDNA into the pCS2+ vector and
producing mRNA with the mMessage-mMachine SP6 kit (Ambion,
Austin, TX).
Radiation exposure and PFTα protection. Triplicate dishes (60 embryos
each) were irradiated at 24 hpf (20 Gy) using 250 kVp X-rays (PanTak, East
Haven, CT) at 50 cm source-to-skin with a 2-mm aluminum filter. Dosimetric calibration was performed before each experiment using a thimble
ionization chamber (Victoreen; Elimpex-Medizintechnik, Moedling, Austria) with daily temperature and pressure correction. Pifithrin-α (EMD
Biosciences, San Diego, CA) was solubilized in DMSO and diluted with
embryo media. PFTα was applied 30 minutes prior to IR.
Kidney function assay. A 1% solution of rhodamine-labeled dextran (10
kDa; Molecular Probes) in PBS was injected (3 dpf ) using glass micropipets into the cardiac venous sinus of embryos immobilized in 3% methyl
cellulose. Prior to injection, embryos were anesthetized using a 0.003%
tricaine solution in egg water.33 After injection, the embryos were washed
in egg water for 10 minutes and placed back into 3% methylcellulose
on a glass depression slide. Fluorescence was quantitated using ImageJ
software (NIH, USA). The analysis was repeated at 24 h after dextran
injection. Percent dextran retention at 24 h was calculated using the formula: (intensity 24 h/intensity 0 h) X 100.
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dextran staining is described in Materials and Methods. Representative images are shown at 0 and 24 h. (B) Quantification of dextran label retention at 24 h
after dye injection. Three embryos per condition were quantified for dye retention using NIH imageJ software.
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Figure 6. PFT-α inhibits p73-dependent transcription of a reporter gene construct. Triplicate wells (48-well plate) were transfected with pCMV- gal and
p53 pr-RLuc plasmids together with either a pCMV-zp53 (A) or a pCMV-zp73 plasmid. (B) Renilla luciferase activity was assayed 48 h post transfection
and normalized to -gal activity as described in the Materials and Methods. Cells were treated with PFT-α 15 minutes before transfection. Asterix (*) p < 0.5
(tukey test); **p < 0.01(tukey test).
Alcian blue staining. Alcian blue staining was performed according to
Neuhauss et al.,34 with the following modifications. Embryos (4 dpf )
were fixed overnight in Davidson’s Solution (Electron Microscopy Sciences, Hatfield, PA) and rinsed 3x for 10 min in PBS and transferred to
neutral buffered formalin for 2 days at 4°C. The embryos were then transferred into distilled water and stored at 4°C. For Alcian blue staining, the
samples were washed in PBT (0.1% Tween-20 in PBS) and transferred
into 30% H2O2 (Sigma, St. Louis, MO) and bleached for 4–5 hours or
until eyes became translucent. After bleaching, the embryos were rinsed
in PBS for 15 min and transferred to filtered Alcian Blue solution (1%
conc HCl, 70% Ethanol, 0.1% Tween-20) and stained overnight. The
stain was cleared with acidic ethanol (5% conc HCl, 70% ethanol).

Acridine orange staining. Zebrafish embryos were dechorionated and
placed in 50 μg/ml of acridine orange (Sigma) in fish water. After 30 min
of staining, embryos were washed 3x for 10 min in PBS. Pooled embryos
were transferred to 95% ethanol for 15 minutes to extract the AO for
fluorescence determination. Triplicate measurements for each condition
were performed on a FL600 microplate fluorescence reader (Bio-Tek)
and normalized to control background fluorescence and reported as relative fluorescence units (RFU).
In vitro reporter gene assays. Saos-2 cells (ATCC Rockville, MD) were
cultured in DMEM supplemented with 10% fetal calf serum. Cells were
cultured to 60–70% confluence and transferred to 48-well plates at a
density of 2.6 x 104 cells/well. Cells were transfected with three plasmids
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using Fugene (Roche). The p53 reporter plasmid was constructed by
inserting the synthetic p53-responsive promoter containing 14 tandem
p53 enhancer elements and a TATA-box (Pathdetect p53-cis reporter,
Stratagene) into the pRLnull plasmid (Promega) to drive the Renilla
luciferase gene (p53 pr-RLuc). For normalization, a B-galactosidase
reporter plasmid was used (pCMV-Bgal;35). Renilla luciferase activity was
measured 48 hrs after transfection using the Dual-Luciferase Reporter
Assay System (Promega, Madison, WI) and B-gal activity was measured
using the Beta-Glo Reporter Assay System (Promega, Madison, WI)
according to the manufacturer’s specifications. Cells were treated
with PFTα 15 minutes before transfection. Chemiluminescence was
measured using a Veritas Microplate luminometer (Turner Biosystems,
Sunnyvale, CA).
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